Effect of Tumor Base Size in Bladder Cancer

Not Applicable

Completed

• Conditions: Bladder Cancer
• Interventions: Procedure: TUR-BT

• Registration Number: NCT06632340
• Lead Sponsor: Ankara Training and Research Hospital

Brief Summary

Investigators aim to investigate the effect of the size of the base of the tumor in contact with the bladder mucosa on recurrence and progression in non-muscle invasive bladder tumors.

Detailed Description

Between March 2021 and September 2023, 130 patients who applied to our clinic with complaints of hematuria, dysuria, and suprapubic pain, and who were diagnosed with bladder tumor by imaging methods and underwent TUR-MT were included in the study. The groups were compared in terms of age, gender, smoking, ASA, comorbidities, BMI and the number of tumors, size, stage as intraoperative and postoperative data. Patients with tumor base size \<2 cm were classified as Group

1, while with tumor base size ≥2 cm were classified as Group 2. Kaplan Meier survival analysis without recurrence and without progression were performed after comparing the groups in terms of recurrence and progression.

Study Timeline

• Study Start: 2021-03-01
• Primary Completion: 2023-09-30
• Study Completion: 2024-01-01
• Status Verified: 2024-10
• Study First Submitted: 2024-10-07
• Study First Submitted QC: 2024-10-07
• Study First Posted: 2024-10-09
• Last Update Submitted: 2024-10-13
• Last Update Posted: 2024-10-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

• Bladder Tumor

Exclusion Criteria

• Invasive Bladder Tumor

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group 1	TUR-BT	tumor base size \<2 cm
Group 2	TUR-BT	tumor base size \>2 cm

Primary Outcome Measures

Name	Time	Method
Recurrence	2 year

Secondary Outcome Measures

Name	Time	Method
progression	2 year

Trial Locations

Locations (1)

Ankara Training and Research Hospital; 🇹🇷 Ankara, Turkey